Cardiovascular Trials Decoded: Heart Health Tips for World Heart Day 2024

At Navitas Life Sciences, we understand the immense impact cardiovascular diseases have on global health, making advancements in treatment essential. Cardiovascular clinical trials, including some landmark cardiology trials, are vital for testing innovative therapies and interventions that can improve patient outcomes and save lives. These trials allow researchers to evaluate new drugs, devices, and treatment protocols in a controlled setting, gathering data that will drive future healthcare solutions. With over three decades of experience, Navitas Life Sciences has established itself as a trusted cardiology CRO, offering comprehensive support for cardiovascular trials of all sizes. Our expertise, combined with cutting-edge technology and data-driven insights, ensures that our clients can accelerate development timelines while maintaining the highest quality standards.

Efficient Cardiovascular Clinical Trials

• 40+ studies
• 2,000+ managed sites
• 28,000+ enrolled patients
• Regional and local studies
• Across Phases and beyond

Through adaptive trial designs, decentralized models, and advanced patient recruitment strategies, we help optimize study protocols and ensure faster, more effective trial execution. Our patient-centered approach focuses on enhancing retention, reducing the burden on participants, and delivering faster, more accurate results. Whether you are working on rare or common cardiovascular conditions, our global network and innovative methodologies offer you the support you need for faster market reach of your cardiovascular drug products.

In honor of World Heart Day 2024, we had the opportunity to speak with Dr. Srikanth K V from Narayana Hrudayalaya Hospital, Bangalore, India, about key factors for heart health, common misconceptions, and the latest in cardiology research. Here's what he had to say:

What are the most important lifestyle factors for maintaining a healthy heart?

Maintaining heart health starts with a balanced lifestyle and finding best foods for heart healthy diet. A diet that includes plenty of fruits, vegetables, whole grains, and lean proteins is essential. Avoiding oily foods and egg yolk can also help. Instead, focus on eating egg whites, seafood, and lean meats like chicken. Exercise is equally important—at least 30 minutes of aerobic activity every day can make a big difference. It’s also important to avoid all forms of tobacco, limit alcohol consumption, and practice stress management techniques like yoga or meditation.

What are some common misconceptions about fitness and heart health, and how can people adopt a more heart-healthy lifestyle through exercise?

A common misconception is that only intense exercise benefits the heart, but moderate, consistent physical activity is just as beneficial. You don’t need to push yourself to extremes—a mix of aerobic and strength training exercises can greatly improve heart health. Another misconception is that heart health is only about exercise, but diet, sleep, and stress management are equally critical. Gradual lifestyle changes that are sustainable in the long term are the best approach.

Please explain the role of cardiovascular clinical trials in advancing heart health

Cardiology trials play a crucial role in improving heart health by testing new medications, procedures, and therapies. These trials provide valuable data that help improve patient care and outcomes. They also drive innovation, leading to the development of advanced technologies and treatment methods that ultimately save lives.

What are the key challenges you face when conducting cardiology trials, and how do you overcome them?

One of the main challenges is recruitment—finding eligible and willing participants can be difficult. Another challenge is ensuring participants follow trial protocols throughout the study. To overcome these, we use technology to streamline recruitment and improve monitoring. Clear communication with participants is also critical to ensure compliance and help them understand the importance of their role in the cardiology trial.

What are the most promising areas of research in cardiology today?

Some of the most exciting areas of research include genetic studies that explore how our genes impact heart disease, as well as regenerative medicine, particularly stem cell therapies aimed at repairing damaged heart tissue. Wearable technology is also promising, as it allows us to monitor heart health in real-time. Additionally, artificial intelligence is being used to enhance diagnostic precision and treatment strategies, which is very exciting.

How important is diversity and inclusion in cardiovascular clinical trials?

Diversity in clinical trials is absolutely essential. We need to ensure that different populations are represented so that we can understand how treatments affect various demographics. This not only provides equal access to the latest therapies but also helps us achieve better and more generalizable results for everyone. Without diversity, we risk missing key insights that could improve patient outcomes.

What is your message to people on World Heart Day?

On World Heart Day, I encourage everyone to make small but impactful changes for their heart health. Eating well, staying active, and managing stress are simple steps that can lead to a stronger heart and a longer life. It’s never too late to start taking care of yourself, and the choices you make today can have a lasting impact. Your heart deserves the best—so commit to healthier habits and make heart health a priority.

Navitas Life Sciences: Efficient Cardiology Trials

Cardiovascular clinical trials are essential for advancing treatment options in the fight against heart disease, and the work done today will shape the future of cardiovascular health for generations to come. At Navitas Life Sciences, we are committed to supporting every phase of cardiology clinical trials, from early feasibility studies to large-scale cardiovascular trials. By leveraging our expertise in cardiovascular research, our global reach, and our innovative technology solutions, we help our clients bring life-changing treatments to market faster and more efficiently.

Cardiology Trials

• Acute Coronary Syndrome
• Acute Myocardial Infarction
• Cardiomyopathy
• Carotid Intima-Media Thickness
• Congestive Heart Failure
• Coronary Artery Bypass Graft Surgery
• Coronary Artery Disease

• Critical Limb Ischemia (CLI)
• Mitral valve regurgitation
• Nonvalvular atrial fibrillation or atrial flutter
• Percutaneous coronary intervention
• Stroke prevention in atrial fibrilation
• Thromboembolic diseases
• Venous leg ulcer

As cardiovascular innovations continue to grow, the need for agile, patient-focused trials has never been more critical. At Navitas Life Sciences, we are dedicated to meeting this challenge with unparalleled support, working to ease the burden on patients and make smarter, data-driven decisions that improve outcomes.

By combining our expertise with innovative technology, we strive to lead the way in cardiology trials, helping bring life-saving treatments to those who need them most. Every trial we support is backed by expertise, experience and robust data support to ensure the best use of resources for our sponsors.